跳至主要内容
临床试验/CTRI/2022/04/042107
CTRI/2022/04/042107尚未招募4 期

A comparative study to evaluate the effectiveness of â??Darvyadi Kwathaand Nishamalaki Churna�? in management of Madhumeha (Type-2 Diabetes)

Chaudhary Brahm Prakash Ayurved Charak Sansthan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION.
  • 2. FBS-126-250mg/dl
  • 3. PPBS 180-400mg/dl
  • 4. HbA1c 6.4 % and more.
  • 5.Patient is taking anti oral diabetic medicine sulphonylureas dosage (glipizide not more then 20mg, glimipride not more then 8mg, glidazidie not more than 180 mg, pioglitazoe not more than 20 mg
  • ) and bigunoids (metformin not more than 1000 mg)
  • 6. Diagnosed case of Diabetes mellitus at least 6 month back

排除标准

  • 1. Patients below the age of 21 years and more than the age of 60 years.
  • 2. Fasting Blood Sugar Level >250 mg/dl •
  • 3. Post Prandial Blood Sugar Level >400 mg/dl
  • 4. HbA1c >10%
  • 5. Patients depending on the insulin for blood glucose control.
  • 6. Patients with diabetic complications.
  • 7. Patients suffering from Secondary Diabetes.
  • 8. Gestational diabetes.
  • 9. Pregnant ladies and lactating mothers.
  • 10. Patient is taking any other oral anti diabetic medicine or combination of any oral anti diabetic medicine.

研究者

发起方
Chaudhary Brahm Prakash Ayurved Charak Sansthan

相似试验